// May 24, 2023
World Vaccine Congress 2023: Spotlight shines on mRNA and viral vectored technology platforms
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Manufacturing products locally for more equitable pandemic responses
How to secure upstream pharmaceutical supply chain risks with data and advanced techn